Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Market Cap	2.55B -22.2%
Revenue (ttm)	567.06M -8.3%
Net Income	76.35M -6.7%
EPS	1.68 -8.0%
Shares Out	44.93M
PE Ratio	33.75
Forward PE	n/a
Dividend	1.75 (3.09%)
Ex-Dividend Date	Jun 26, 2025

Volume	2,085
Average Volume	25,367
Open	56.60
Previous Close	56.90
Day's Range	56.60 - 56.70
52-Week Range	56.50 - 88.30
Beta	-0.14
RSI	38.55
Earnings Date	Mar 30, 2026

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 199
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2024, TPEX:4747's revenue was 611.42 million, an increase of 0.78% compared to the previous year's 606.71 million. Earnings were 84.12 million, an increase of 5.55%.